| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |